Bill
SF 2326
Overview: SF 2326, "Certain billboards advertising prohibition elimination provision", was referred to the Commerce and Consumer Protection committee after being introduced on Marc
Overview: SF 2326, "Certain billboards advertising prohibition elimination provision", was referred to the Commerce and Consumer Protection committee after being introduced on March 10, 2025.
Purpose and Intent: The main goal of this bill is to eliminate the existing prohibition on certain types of billboards, particularly those advertising pharmaceutical products and other regulated goods. The intent is to provide more flexibility for businesses and industries to advertise their products and services through outdoor advertising.
Key Provisions:
- Repeals the current ban on billboards advertising prescription drugs, controlled substances, and other regulated products
- Allows for the placement of such billboards, subject to any necessary permitting and zoning requirements
- Removes restrictions on the content, size, and placement of these types of billboards
Affected Parties and Impacts: This bill would primarily affect the outdoor advertising industry, as well as businesses and industries that rely on billboard advertising, such as the pharmaceutical and healthcare sectors. Consumers may also be impacted through increased exposure to advertising for regulated products.
Procedural and Timeline Considerations: The bill has been referred to the Commerce and Consumer Protection committee for further review and potential amendments. If reported favorably, it would then move to a vote by the full state legislature. The timeline for consideration and passage is uncertain at this stage.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
